Perioperative Chemotherapy Strategies in Diffuse Gastric Cancer

Overview

Journal World J Gastrointest Surg

Publisher Baishideng Publishing Group

Date 2025 Jan 28

PMID 39872775

Authors

Niloufar Salehi

Maria Alqamish

Rasa Zarnegar

Affiliations

Soon will be listed here.

Abstract

This study reviews the findings of a recent study by Li , which demonstrated that perioperative chemotherapy benefits patients with diffuse-type gastric cancer compared to surgery alone. Despite potential biases, the study supports the inclusion of perioperative chemotherapy in treatment guidelines. Neoadjuvant and adjuvant chemotherapy may also provide similar survival outcomes, allowing for flexible treatment planning.

References

Gertsen E, van der Veen A, Brenkman H, Brosens L, van der Post R, Verhoeven R . Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study. Ann Surg Oncol. 2023; 31(3):1760-1772. DOI: 10.1245/s10434-023-14690-y. View

van der Kaaij R, Koemans W, van Putten M, Snaebjornsson P, Luijten J, van Dieren J . A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015. Eur J Cancer. 2020; 130:23-31. DOI: 10.1016/j.ejca.2020.02.017. View

LAUREN P . THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965; 64:31-49. DOI: 10.1111/apm.1965.64.1.31. View

Pietrantonio F, Miceli R, Raimondi A, Kim Y, Kang W, Langley R . Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. J Clin Oncol. 2019; 37(35):3392-3400. DOI: 10.1200/JCO.19.01124. View

Li Z, Zhang Q, Teng L, Zhang C, Huang Y . Comparable rates of lymph node metastasis and survival between diffuse type and intestinal type early gastric cancer patients: a large population-based study. Gastrointest Endosc. 2019; 90(1):84-95.e10. DOI: 10.1016/j.gie.2019.03.002. View

. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513(7517):202-9. PMC: 4170219. DOI: 10.1038/nature13480. View

Messager M, Lefevre J, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C . The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011; 254(5):684-93. DOI: 10.1097/SLA.0b013e3182352647. View

Gill S, Shah A, Le N, Cook E, Yoshida E . Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. J Clin Oncol. 2003; 21(11):2070-6. DOI: 10.1200/JCO.2003.11.054. View

Ilic M, Ilic I . Epidemiology of stomach cancer. World J Gastroenterol. 2022; 28(12):1187-1203. PMC: 8968487. DOI: 10.3748/wjg.v28.i12.1187. View

10.

Cunningham D, Allum W, Stenning S, Thompson J, van de Velde C, Nicolson M . Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355(1):11-20. DOI: 10.1056/NEJMoa055531. View

11.

Al-Batran S, Homann N, Pauligk C, Goetze T, Meiler J, Kasper S . Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma.... Lancet. 2019; 393(10184):1948-1957. DOI: 10.1016/S0140-6736(18)32557-1. View

12.

Sohn B, Hwang J, Jang H, Lee H, Oh S, Shim J . Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. Clin Cancer Res. 2017; 23(15):4441-4449. PMC: 5785562. DOI: 10.1158/1078-0432.CCR-16-2211. View

13.

Li Z, Li Z, Zhang X, Sun C, Fei H, Du C . Perioperative chemotherapy improves survival of patients with locally advanced diffuse gastric cancer. World J Gastrointest Surg. 2024; 16(9):2878-2892. PMC: 11438797. DOI: 10.4240/wjgs.v16.i9.2878. View

14.

Kang Y, Yook J, Park Y, Lee J, Kim Y, Kim J . PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer. J Clin Oncol. 2021; 39(26):2903-2913. PMC: 8425847. DOI: 10.1200/JCO.20.02914. View

15.

Zhou K, Wang A, Wei J, Ji K, Li Z, Ji X . The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy. Front Oncol. 2022; 11:789104. PMC: 8784750. DOI: 10.3389/fonc.2021.789104. View